A-A-54456
26 July 1991
COMMERCIAL ITEM DESCRIPTION
PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-P-37495 which is cancelled.
Salient characteristics:
Shall be Prednisolone Acetate Ophthalmic Suspension, USP.
Shall be in accordance with the requirement of the USP.
All ingredients shall be of a pharmaceutical grade.
Strength.
For Strength 1, the suspension shall contain 0.125 percent Prednisolone Acetate, USP, within the applicable assay limits for the suspension.
For Strength 1, the suspension shall contain 1.0 percent Prednisolone Acetate, USP, within the applicable assay limits for the suspension.
Workmanship. The suspension shall be free from defects which detract from its appearance or impair its serviceability.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business